Double-negative T cells remarkably promote neuroinflammation after ischemic stroke.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30819895.
- Also identified by DOI 10.1073/pnas.1814394116 and PMC identifier 6431175.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CD3<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> T cells (double-negative T cells; DNTs) have diverse functions in peripheral immune-related diseases by regulating immunological and inflammatory homeostasis. However, the functions of DNTs in the central nervous system remain unknown. Here, we found that the levels of DNTs were dramatically increased in both the brain and peripheral blood of stroke patients and in a mouse model in a time-dependent manner. The infiltrating DNTs enhanced cerebral immune and inflammatory responses and exacerbated ischemic brain injury by modulating the FasL/PTPN2/TNF-α signaling pathway. Blockade of this pathway limited DNT-mediated neuroinflammation and improved the outcomes of stroke. Our results identified a critical function of DNTs in the ischemic brain, suggesting that this unique population serves as an attractive target for the treatment of ischemic stroke.
Medical subject headings
- Brain Ischemia
- CD3 Complex
- Stroke
- T-Lymphocyte Subsets